ZNF322A anticorps (N-Term)
Aperçu rapide pour ZNF322A anticorps (N-Term) (ABIN927552)
Antigène
Voir toutes ZNF322A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Souris, Rat (Rattus), Boeuf (Vache)
-
Purification
- Purified
-
Immunogène
- ZNF322 A antibody was raised in rabbit using the N terminal of ZNF322 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ZNF322A Blocking Peptide, (ABIN5617163), is also available for use as a blocking control in assays to test for specificity of this ZNF322A antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ZNF322A (Zinc Finger Protein 322A (ZNF322A))
-
Autre désignation
- ZNF322A
-
Sujet
- ZNF322 contains four exons and spans 23.2kb in chromosome 6p22.1 region, and transcribes a 2.7kb mRNA that encodes a protein with 402 amino acid residues.Through northern blot analysis, ZNF322 was shown to be expressed in every human tissue examined at adult stage and during embryonic developmental stages from 80 days to 24 weeks. When ZNF322 was overexpressed in COS-7 cells, ZNF322-EGFP fusion protein is detected in the nucleus and cytoplasm. Reporter gene assays show that ZNF322 is a transcriptional activator. Synonyms: Polyclonal ZNF322A antibody, Anti-ZNF322A antibody, zinc finger protein 322A antibody.
Antigène
-